首页|基于网络药理学探讨白芍治疗慢性萎缩性胃炎的分子机制研究

基于网络药理学探讨白芍治疗慢性萎缩性胃炎的分子机制研究

扫码查看
目的:采用网络药理学方法,对白芍治疗慢性萎缩性胃炎(Chronic Atrophic Gastritis,CAG)的作用机制进行探讨.方法:运用中药系统药理学数据库与分析平台(TCMSP)获得白芍有效活性成分与相应靶点信息.通过GeneCards、OMIM、DisGeNET数据库搜集CAG的相关靶标信息,并通过Venny 2.1.0 取得药物与疾病靶点的交集.分别采用Cytoscape 3.7.1、STRING数据库绘制"药物活性成分-靶点"网络图与蛋白质-蛋白质相互作用网络图,行可视化处理.借助DAVID数据库行基因本体论(GO)功能、京都基因与基因组百科全书(KEGG)通路富集分析.最后用软件Cytoscape 3.7.1绘制"药物成分-靶点-通路-疾病"网络.结果:得到白芍活性成分 8 个、作用靶点 72 个,疾病靶点 972 个,二者交集 34 个.关键活性成分有山柰酚、β-谷甾醇、儿茶素,关键靶点有丝氨酸/苏氨酸蛋白激酶 1(Akt Serine/Threonine Kinase 1,AKT1)、肿瘤坏死因子、白细胞介素-6 等;白芍主要通过参与凋亡过程阳性调节、对药物的反应、炎症反应等生物过程,调节癌症的途径、晚期糖基化终末产物(Advanced Glycation End products,AGE)-晚期糖基化终末产物受体(Advanced Glycation End products Receptor,RAGE)、爱泼斯坦-巴尔病毒感染等通路来发挥抗CAG的作用.分子对接结果显示,筛选出的药物活性成分与关键靶标间具有较好的结合活性.结论:本研究已初步揭示白芍抗CAG的作用机制,为CAG在中医药领域的治疗作用及新的药物研发奠定基础.
Network pharmacology-based research on the mechanism of action of Baishao in the treatment of chronic atrophic gastritis
Objective:The network pharmacology method was used to examine the mechanism of action of Baishao(Radix Paeoniae Alba)in the treatment of chronic atrophic gastritis(CAG).Methods:The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)was used to obtain information on the active ingredients and corresponding targets of Baishao.The information on targets associated to CAG was acquired through GeneCards,OMIM and DisGeNET databases,and drug-disease target intersection was retrieved through Venny 2.1.0.Active ingredient-target network diagram and PPI network diagram were generated using Cytoscape 3.7.1 and STRING databases,and then visualized.The DAVID database was used to conduct the Gene Ontology(GO),Kyoto Encyclopedia of Gene and Genomes(KEGG)enrichment study.Finally,Cytoscape 3.7.1 software was used to map the drug component-target-pathway-disease network diagram.Results:A total of 8 active components,72 targets,972 disease targets,and 34 intersections were discovered.Kaempferol,beta-sitosterol,(+)-catechin,AKT1,TNF,IL-6 were important active components and genes.Baishao primarily participated in the positive regulation of apoptotic process,response to drug,inflammatory response,and other biological processes to treat CAG by regulating signal pathways such as pathways in cancer,AGE-RAGE signaling pathway in diabetic complications,Epstein-Barr virus infection.Molecular docking results showed that the selected drug active ingredients have good binding activity with key targets.Conclusion:This research has preliminarily identified the anti-CAG mechanism of Baishao,laying the groundwork for both the creation of novel medications and the TCM treatment of CAG.

Network pharmacologyBaishaoChronic atrophic gastritisAactive componentAction mechanism

柳嘉茜、李玟静、许梦萍、杨家耀

展开 >

湖北中医药大学中医临床学院,湖北 武汉,430000

武汉市中西医结合医院,湖北 武汉,430022

网络药理学 白芍 慢性萎缩性胃炎 活性成分 作用机制

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(7)
  • 29